Top Markets
#1 Official Trump Official Trump +39.89%
#2 Melania Meme Melania Meme +20.05%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.56%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +17.46%
#6 Wrapped POL Wrapped POL +16.68%
#7 POL (ex-MATIC) POL (ex-MATIC) +16.52%
#8 Mubarak Mubarak +15.50%
#9 Unit Pump Unit Pump +10.98%
#10 Pump.fun Pump.fun +10.98%
Coin of the day
Official Trump Official Trump
設定
言語
日本
通貨
USD
テーマ
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
株式のランク #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
株価
$19.30
最終同期: 2023-12-26
時価総額
$72.77M
変化（1日）
6.22%
変化（1年）
0.00%
国
US
取引 Aeglea BioTherapeutics, Inc. (AGLE)

カテゴリー

Healthcare
Aeglea BioTherapeutics, Inc.（AGLE）の配当利回りの履歴
Aeglea BioTherapeutics, Inc.（銘柄コード: AGLE）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Aeglea BioTherapeutics, Inc.（AGLE）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH